A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
for Macular Degeneration
48 locations incl. Gilbert
Sponsor: EyeBiotech Ltd.
Sex: All·Age: 50+
Code: NCT07496567·Phase 2, Phase 3·Recruiting·Listed Mar 2026
Retina Consultants of Texas
Clinical research site in Schertz, Texas
Part of Retina Consultants of Texas
As of July 2026, 3 paid clinical trials are recruiting at Retina Consultants of Texas in Schertz, Texas. Active studies at this site cover conditions such as Age-Related Macular Degeneration, Choroidal Neovascularization and DME. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Retina Consultants of Texas (3)
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
for Diabetic Macular Edema
50 locations incl. Bakersfield
Sponsor: EyePoint Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT07449936·Phase 3·Recruiting·Listed Mar 2026
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
for Neovascular Age-related Macular Degeneration
33 locations incl. Mesa
Sponsor: Genentech, Inc.
Sex: All·Age: 50+
Code: NCT04853251·Phase 4·Recruiting·Listed Apr 2021
More research sites in Schertz
- Adverum Clinical (1 trial)
- Retina Consultants of Texas (01055) (1 trial)
- Retina Consultants of Texas - Schertz (1 trial)